The Management of Ibrahim Badamasi Babangida University, Lapai (IBBUL) has reaffirmed its preparedness to undertake research into seroprevalence of Covid-19 pandemic in Niger State and Nigeria.
Speaking on the topic, the Vice Chancellor, Professor Abu Kasim Adamu who led the team of discussants at Prestige FM, Minna, said the University approved the research to contribute its own quota to curb the Pandemic as a recognized centre of excellence in teaching, research and community service.
In his contribution, the Head of the Research team, Dr. Hussaini Majiya said the team was up to the task and would do its best to ensure that IBB University registers her name in gold among the institutions carrying out research into the prevention, management and seeking cure for the deadly Covid-19 pandemic.
Dr. Majiya who is the Head of Microbiology said his team comprised multidisciplinary researchers and relevant stakeholders with vast knowledge and experience. He therefore, called for full support and cooperation from the State Government and other citizens towards realising the objectives of the project.
Commenting, the Deputy Vice Chancellor, Academic, Dr. Mohammed Aliyu Paiko expressed the confidence that with the expertise at its disposal, the University was hopeful for a successful outcome for the benefit of the country.
A former Permanent Secretary in the State Ministry of Health, Dr. Chindo Ibrahim Bisala in his contribution, eulogized the State for being among the first to take proactive measures that have helped to stem the spread of the pandemic in the country.
It may be recalled that the Vice-Chancellor of the institution, Professor Abu Kassim Adamu had recently inaugurated a team of scientists to carry out high impact research that would lead to the development of an efficient vaccine against Covid-19 in Nigeria, using Niger State for pilot study.
The Seroprevalence study of Covid-19 infections in Niger state is one among such numerous proposals that were approved by IBBUL management.
Others include exploring potential of extracts from plants abundant in our local flora against Covid-19 infection, transmission and as sources of antioxidants to boost the human Immune system. Vaccine development is also included in the research prospects of the IBBUL.